A South San Francisco company looked at its single drug and the cash needed to get it approved, then played its hand against a global pharma giant.
Read More from Bizjournals.com Feed (2025-02-17 17:47:29)
Bay Area drug company secures $3.5 billion acquisition amid funding challenges
